146 related articles for article (PubMed ID: 27452410)
1. Can reduction of uncertainties in cervix cancer brachytherapy potentially improve clinical outcome?
Nesvacil N; Tanderup K; Lindegaard JC; Pötter R; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):390-396. PubMed ID: 27452410
[TBL] [Abstract][Full Text] [Related]
2. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
3. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate.
Song W; Schaly B; Bauman G; Battista J; Van Dyk J
Med Phys; 2005 Jul; 32(7Part1):2193-2203. PubMed ID: 28493587
[TBL] [Abstract][Full Text] [Related]
4. Investigation of whether in-room CT-based adaptive intracavitary brachytherapy for uterine cervical cancer is robust against interfractional location variations of organs and/or applicators.
Oku Y; Arimura H; Nguyen TT; Hiraki Y; Toyota M; Saigo Y; Yoshiura T; Hirata H
J Radiat Res; 2016 Nov; 57(6):677-683. PubMed ID: 27296250
[TBL] [Abstract][Full Text] [Related]
5. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
6. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate.
Song W; Schaly B; Bauman G; Battista J; Van Dyk J
Med Phys; 2005 Jul; 32(7):2193-203. PubMed ID: 16121573
[TBL] [Abstract][Full Text] [Related]
7. A method to visualize the uncertainty of the prediction of radiobiological models.
Zhang L; Hub M; Thieke C; Floca RO; Karger CP
Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
[TBL] [Abstract][Full Text] [Related]
8. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer.
Kirisits C; Lang S; Dimopoulos J; Oechs K; Georg D; Pötter R
Radiother Oncol; 2006 Dec; 81(3):269-75. PubMed ID: 17126938
[TBL] [Abstract][Full Text] [Related]
9. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
Song W; Battista J; Van Dyk J
Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
[TBL] [Abstract][Full Text] [Related]
10. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
11. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
12. Intra-fraction uncertainties of MRI guided brachytherapy in patients with cervical cancer.
Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Westerveld H; Jürgenliemk-Schulz IM
Radiother Oncol; 2014 Aug; 112(2):217-20. PubMed ID: 25216574
[TBL] [Abstract][Full Text] [Related]
13. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study.
Petrič P; Hudej R; Rogelj P; Blas M; Tanderup K; Fidarova E; Kirisits C; Berger D; Dimopoulos JC; Pötter R; Hellebust TP
Radiother Oncol; 2013 Apr; 107(1):6-12. PubMed ID: 23453539
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
[TBL] [Abstract][Full Text] [Related]
16. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
17. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
[TBL] [Abstract][Full Text] [Related]
18. Impact of delineation errors on the estimated organ at risk dose and of dose errors on the normal tissue complication probability model.
Mövik L; Bäck A; Pettersson N
Med Phys; 2023 Mar; 50(3):1879-1892. PubMed ID: 36693127
[TBL] [Abstract][Full Text] [Related]
19. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer.
Tanderup K; Hellebust TP; Lang S; Granfeldt J; Pötter R; Lindegaard JC; Kirisits C
Radiother Oncol; 2008 Nov; 89(2):156-63. PubMed ID: 18692265
[TBL] [Abstract][Full Text] [Related]
20. The effect of alternative biological modelling parameters (α/β and half time of repair T ½ ) on reported EQD2 values in the treatment of advanced cervical cancer.
De Leeuw AA; Van de Kamer JB; Moerland MA; Philippens ME; Jürgenliemk-Schulz IM
Radiother Oncol; 2011 Nov; 101(2):337-42. PubMed ID: 21742393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
